Trial
NCT00095017
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083)
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Organon and Co
Collaborators
—
Condition
Bone Neoplasms
Intervention
MK0663, etoricoxib / Duration of Treatment: 4 weeks
Why stopped
—
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2022-02-16